More on OGN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.53 |
|
|||
| Open | $13.57 | ||||
| 52 Wk High | $8.00 | ||||
| 52 Wk Low | $8.00 | ||||
| Day High | $13.59 | ||||
| Day Low | $13.53 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,508,071 | ||||
- Organon launches two denosumab biosimilars in Canada
- Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
- Organon closes license deal for copper IUD Miudella with Sebela
- Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
- Organon and Samsung Bioepis add ustekinumab biosimilar to Canada deal
- Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
- Form 4 Organon & Co. For: Jun 12 Filed by: Sharp Shalini
- Form 4 Organon & Co. For: Jun 12 Filed by: Sequeira Ramona
- Form 4 Organon & Co. For: Jun 12 Filed by: Patton Cynthia M
- Form 4 Organon & Co. For: Jun 12 Filed by: Ozuah Philip
Entities mentioned with OGN
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Show More...
